We are a life sciences data science company focusing primarily on streamlining the process of drug re-purposing and discovery using AI and Deep Learning technologies. Our founders have also worked in the healthcare insurance sector and conceived of neural network-based solutions. We have multiple IPs in US patents in machine learning and data engineering. Our founding team also consists of prolific researchers and authors in the computer sciences, cancer biology and clinical research and trials.

While we are an US-based company, our team prides itself on being able to communicate in a wide range of languages, including English, French and Hebrew, and being able to connect and work with a clients of diverse backgrounds.